Account
Uber awards digital mandate to Dentsu Webchutney for India, South Asia
MUMBAI: Following a multi-agency pitch, Dentsu Webchutney, the digital agency from Dentsu Aegis Network, has won the digital and social media duties for Uber in the India and South Asia region.
The account will operate out of the agency’s Bengaluru office.
Uber India and South Asia head of marketing Sanjay Gupta says, “Dentsu Webchutney is an agency that has a track record of working on some of the most dynamic and impactful digital campaigns. We believe they have the right expertise for a brand like Uber. Uber’s journey in the region is only getting started and we are excited to partner with Dentsu Webchutney to tell the story of how Uber is shaping the future of urban mobility in India.”
Dentsu Webchutney executive vice president Gautam Reghunath adds, “We long for opportunities to partner with consequential companies that shape society. More and more, technology brands expect dexterity in understanding their core vision, for solutions that marry the future to the present. This chance to work towards realising Uber’s vision is a true privilege. Our interactions with the team here have been a wonderful bonus and we see both sides challenging each other in our quest to create meaningful, effective work.”
With this new association, Dentsu Webchutney has added another technology brand in its client roster, joining others like Flipkart, Airtel and Quikr.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
